CMPS - Wutah pendapatan YoY sajrone 12 wulan kepungkur COMPASS Pathways plc

The high scalability potential of COMPASS Pathways plc (CMPS) is driven by low costs following the certification of its psilocybin-based therapy. The YoY commercial revenue growth for the LTM reflects the current trend, where the metric value stands at 0.00. Patent protection for the COMP360 molecule establishes a foundation for market dominance, while the development strategy relies on academic partnerships without external acquisitions.

Wutah dodolan YoY sajrone rolas wulan kepungkur Compass Pathways (CMPS): kanggo periode 11.02.2024 - 15.11.2026

compasspathways.com (CMPS) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:

Rega bursa Compass Pathways|CMPS - Prakiraan konsensus analis

- statistik kapitalisasi pasar:

Biji pasar COMPASS Pathways PLC|CMPS - Nilai Total Perusahaan

- data nilai buku modal saham:

Nilai Aset Bersih saben Saham COMPASS Pathways|CMPS - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih compasspathways.com|CMPS - Aset Agregat Perusahaan

- data tingkat utang lan likuiditas finansial:

Utang Agregat marang Ekuitas COMPASS Pathways plc|CMPS - Utang jangka dawa marang modal|Utang jangka cendhak marang modal COMPASS Pathways PLC|CMPS - Utang perusahaan|Utang-utang marang aset resik COMPASS Pathways PLC|CMPS - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak COMPASS Pathways|Rasio jangkoan perantara compasspathways.com

- rincian bathi lan kelipatan pasar:

CMPS - Bathi resik perusahaan|Bathi forward COMPASS Pathways plc|CMPS - Pangali P/E|Pangali Forward P/E COMPASS Pathways|CMPS - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan COMPASS Pathways plc|CMPS - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku COMPASS Pathways|CMPS - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan compasspathways.com|CMPS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep COMPASS Pathways plc

- data dodolan lan asil:

CMPS - Dodolan perusahaan|Volume dodolan sing dikarepake perusahaan COMPASS Corp|CMPS - Rasio rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Compass Pathways|CMPS - Wutah pendapatan YoY sajrone 12 wulan kepungkur

Analisis kabeh metrik perusahaan:CMPS COMPASS Corp

This indicator integrates quarterly reports and market quotes into a continuous stream, measuring business expansion dynamics via a rolling annual revenue growth rate. By analyzing the current year-over-year (TTM) revenue growth, investors assess the ability of COMPASS Pathways plc (CMPS) to monetize its patent protection for synthetic psilocybin under strict FDA oversight, where any deceleration in growth rates signals regulatory risks.

Pesaing COMPASS Pathways plc (CMPS)

Alkermes Inc. (ALKS) - Wutah pendapatan taun lumaku|Avadel Corp - Wutah dodolan YoY (TTM)|ATAI - Wutah dodolan YoY (TTM)|GHRS: Wutah dodolan YoY (TTM)|MNMD - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur LBRX|Bright Minds Biosciences Inc (DRUG) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) VNDA|Wutah pendapatan taunan sajrone rolas wulan kepungkur Cybin Inc|Alto Neuroscience - Wutah pendapatan YoY sajrone 12 wulan kepungkur|NRXP (NRx Pharmaceuticals, Inc.) - Wutah dodolan taun lumaku|CING - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan taun lumaku SILO|China Pharma Holdings, Inc. (CPHI) - Wutah dodolan YoY sajrone rolas wulan kepungkur|CMND - Wutah pendapatan taunan sajrone rolas wulan kepungkur|PBM (Psyence Biomedical) - Wutah dodolan YoY (TTM)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Clearmind Medicine (SPRC)|Wutah dodolan YoY (TTM) SEEL|VRPX (Virpax Pharmaceuticals, Inc.) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) KRTX (Karuna Therapeutics Inc)